Investment
Features
FeesSafety
Academy
More
Pluang+

Compare STMicroelectronics NV (STM) vs Zoetis Inc (ZTS) Price & Performance

STMicroelectronics NVTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

STMicroelectronics NV vs Zoetis Inc — how do they compare? STMicroelectronics NV trades at $52.06 (market cap $48.14B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: STMicroelectronics NV is the larger of the two by market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold STMicroelectronics NV for 64 Days and Zoetis Inc for 70 Days on average.

STMZTS
Market Cap
$48.14B$30.20B
Volume
9,776,0156,175,327
Sector
TechnologyHealth
52-Week High
$79.91$147.53
52-Week Low
$21.20$69.09
Typical Hold Time
64 Days70 Days
Enterprise Value
$45.66B$37.76B
Dividend Yield
0.68%2.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

STMicroelectronics NV

STM trades at $52.71, down 6.18% on the day, with a bearish technical signal and mixed fundamentals. The company reported Q2 2026 EPS beat ($0.31 vs. $0.26 expected) but missed in Q4 2025 and Q1 2026. Revenue declined from $16.1B in 2022 to $11.8B in 2025, with net income margin turning negative at -0.39% in 2026. Analyst consensus remains positive with a $77.31 price target (51.72% buy ratings), supported by strong AI data-center revenue projections exceeding $2B by 2027 (Reuters, 2026-09-09).

STM faces near-term profitability challenges but offers long-term growth potential in AI and automotive semiconductors. Key risks include execution on margin recovery and macroeconomic volatility. The stock trades at a premium P/E of 101.49, requiring sustained earnings acceleration to justify valuation. Institutional sentiment is cautiously optimistic given the 46% upside to consensus target.

Zoetis Inc

Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal despite mixed moving averages and oscillators. The company shows strong profitability with a 27.69% net income margin and 64.91% ROE, though recent quarterly earnings have been inconsistent. Analyst consensus is a $87.33 price target with no sell ratings. Recent news highlights near-term headwinds in U.S. companion animal sales but underscores long-term resilience and undervaluation.

ZTS presents a compelling value opportunity with a low P/E of 11.92 and robust margins, but faces risks from competitive pressures and volatile earnings. Upside potential exists if the company executes on international growth and maintains its industry-leading profitability, though investors should monitor Q3 2026 results for confirmation of recovery trends.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

STM
100% Buy0% Sell
Avg holding period · 64 Days
ZTS

No sentiment data available yet.

About STMicroelectronics NV

A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.

Read more on STM →

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS →